Ainos, Inc.

AIMD · Nasdaq · SIC 2834: Pharmaceutical Preparations
239
SEC Filings

Business Summary

Ainos, Inc. is a Texas-incorporated dual-platform company advancing AI-based scent digitization technologies and immune therapeutics. Its core platform, AI Nose, integrates gas sensor arrays with proprietary smell language model (SLM) AI to digitize volatile organic compound signals into machine-readable Smell ID data for industrial and healthcare applications. The company also develops VELDONA, a low-dose oral interferon alpha formulation targeting rare, autoimmune, and infectious disease indications, and has commercialized VELDONA Pet supplements in Taiwan.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAIMDdiscussed_in_filing Artificial Intelligence
topic_mentionAIMDdiscussed_in_filing Cybersecurity
topic_mentionAIMDdiscussed_in_filing Trusted Computing
topic_mentionAIMDdiscussed_in_filing Blockchain & Crypto
topic_mentionAIMDdiscussed_in_filing Semiconductor
topic_mentionAIMDdiscussed_in_filing Robotics
topic_mentionAIMDdiscussed_in_filing Supply Chain
topic_mentionAIMDdiscussed_in_filing Regulation
topic_mentionAIMDdiscussed_in_filing Healthcare & Bio
topic_mentionAIMDdiscussed_in_filing AI Compute
topic_mentionAIMDdiscussed_in_filing Platform & Ecosystem
topic_mentionAIMDdiscussed_in_filing Sovereign & Government
topic_mentionAIMDdiscussed_in_filing Artificial Intelligence
topic_mentionAIMDdiscussed_in_filing Cybersecurity
topic_mentionAIMDdiscussed_in_filing Trusted Computing
topic_mentionAIMDdiscussed_in_filing Blockchain & Crypto
topic_mentionAIMDdiscussed_in_filing Semiconductor
topic_mentionAIMDdiscussed_in_filing Robotics
topic_mentionAIMDdiscussed_in_filing Supply Chain
topic_mentionAIMDdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001493152-26-013579EDGAR58K words
2025-03-072024-12-310001493152-25-009568EDGAR—
2024-03-082023-12-310001654954-24-002897EDGAR—
2023-04-032022-12-310001654954-23-004157EDGAR—
2022-03-212021-12-310001654954-22-003463EDGAR—
2021-03-302020-12-310001654954-21-003517EDGAR—
2020-03-302019-12-310001437749-20-006575EDGAR—
2019-04-162018-12-310001014763-19-000004EDGAR—
2018-04-182017-12-310001014763-18-000004EDGAR—
2017-04-172016-12-310001014763-17-000003EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022312EDGAR20K words
2025-08-132025-06-300001493152-25-011908EDGAR—
2025-05-142025-03-310001641172-25-010264EDGAR—
2024-11-062024-09-300001493152-24-043832EDGAR—
2024-08-052024-06-300001493152-24-030251EDGAR—
2024-05-132024-03-310001493152-24-018885EDGAR—
2023-11-092023-09-300001654954-23-014023EDGAR—
2023-08-112023-06-300001654954-23-010601EDGAR—
2023-05-122023-03-310001654954-23-006377EDGAR—
2022-11-142022-09-300001654954-22-015091EDGAR—
2022-08-152022-06-300001654954-22-011233EDGAR—
2022-05-162022-03-310001654954-22-006967EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001493152-26-013578EDGAR2K words
2026-01-060001493152-26-000517EDGAR—
2026-01-050001493152-26-000271EDGAR—
2025-12-310001493152-25-029794EDGAR—
2025-11-130001493152-25-022311EDGAR—
2025-10-170001493152-25-018460EDGAR—
2025-09-080001493152-25-012781EDGAR—
2025-08-130001641172-25-023515EDGAR—
2025-08-070001493152-25-011679EDGAR—
2025-07-310001493152-25-011520EDGAR—

239 total filings indexed. 207 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

semiconductor-manufacturing robotics-and-smart-manufacturing point-of-care-testing-(healthcare) rare-and-autoimmune-disease-therapeutics companion-animal-health women's-vaginal-health senior-care-monitoring environmental-monitoring

Company Identity

CIK0001014763
TickerAIMD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedTX

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: be8b8d5133d1c4f9573ddcfcc91e0038f77dd7c4624b983f57bd0ecb6f77922b
parent: c92af46c7f70b685333e26b538e47a5067832b75cca90f6c0f1ba548b8b5a451
content hash: 7187ae775fefd2f2df874cc25caaf1fbd68c08349809b3a384120ab5e4d84a08
signed: 2026-04-13T04:43:32.909Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf